UBS Group’s GMO US Value ETF GMOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-271
Closed -$7.61K 11290
2026
Q1
$7.61K Buy
+271
New +$7.72K ﹤0.01% 8561
2025
Q3
Sell
-273
Closed -$6.9K 11207
2025
Q2
$6.9K Buy
+273
New +$6.53K ﹤0.01% 9057
2025
Q1
Sell
-615
Closed -$15K 10903
2024
Q4
$15K Buy
+615
New +$15.6K ﹤0.01% 8058

Other funds holding GMOV

UBS Group's GMOV Position: Q2 2026 in Review

UBS Group sold out of GMO US Value ETF (GMOV) in Q2 2026, closing a stake of 271 shares — an estimated $7.61K sold.

UBS Group first reported a position in GMOV in Q4 2024 and held it in 3 quarters. The position peaked at $15K in Q4 2024. 19 funds tracked by Wall St. Rank hold GMOV as of Q2 2026.

  • UBS Group reported no remaining GMO US Value ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 271 GMO US Value ETF shares in Q2 2026, an estimated $7.61K.
  • UBS Group first reported a position in GMO US Value ETF in Q4 2024 and held it in 3 quarters.
  • UBS Group's GMO US Value ETF position peaked at $15K in Q4 2024.
  • 19 funds tracked by Wall St. Rank held GMO US Value ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.